Sector Category: Life Sciences

Vascular Therapies

Vascular Therapies

Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.

Read More
Trellis Bioscience

Trellis Bioscience

Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.

Read More
Therox

Therox

Acquired by Zoll Medical. Developer of SuperSaturated Oxygen (SSO2) therapy to complement percutaneous coronary intervention.

Read More
Svelte Medical Systems

Svelte Medical Systems

Developer of a radial drug-eluting stent platform to simplify cardiovascular stenting procedures.

Read More
Resolve Therapeutics

Resolve Therapeutics

Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.

Read More
PerceptiMed

PerceptiMed

Provider of an automated solution for pharmacy pill-dispensing.

Read More
Oxyrane

Oxyrane

Focused on the development of next-generation enzyme replacement therapies for lysosomal storage diseases based on a yeast-based platform.

Read More
Ovizio Imaging Systems

Ovizio Imaging Systems

Provider of digital holographic microscopy technology.

Read More
Escalier Biosciences

Escalier Biosciences

Focused on the development of small molecule therapies for psoriasis.

Read More
Cambridge Epigenetix

Cambridge Epigenetix

Focused on the development of tools for epigenetic analysis.

Read More
Novadip

Novadip

Focused on the development of therapies for hard and soft tissue reconstruction from autologous adipose stem cells.

Read More
Paradigm Diagnostics

Paradigm Diagnostics

Acquired by Exact Sciences. Provider of a molecular diagnostic test to guide clinical decision making for cancer patients.

Read More